an exciting event appealing to advanced and beginner ... · michael john mihm, phd, associate...
Post on 16-Jul-2020
4 Views
Preview:
TRANSCRIPT
TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE
Forum MedicAl WritingClinical Regulatory
Ensure structured content, efficient review processes and streamline submissions
while remaining compliant with the changing regulatory guidelines
SpeAkerS:Aaron Bernstein PhD, Director, Clinical Medical WritingACTAVIS
Impact of Clinical Trial Registration and
Results Disclosure on Medical Writing
ICH M4 Guidelines and the Increasing
Need for US Integrated Summaries
Medical Writing Challenges in Creating a
Global New Drug Application
Examine the Changing Trends in
Resourcing
Standardization of Protocol Documents
and Component Authoring
New Implementation of Metrics to Measure
Operational Effectiveness
Structured Content Management to
Increase Quality and Decrease Workload
Emerging Importance of Patient
Reported Outcomes
event highlightS
TO REGISTER CALL: 201 871 0474
July 14-15, 2014 | Loews philadelphia hotel | philadelphia, pA
TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE
Joan Affleck Associate Vice President, Global Head of Clinical Documentation SANOFI
• Kim Norris, Director, Medical Writing,SYNTA PHARMACEUTICALS
• Jane Stephenson, PhD, MBA, Director of Medical Writing,BOEHRINGER INGELHEIM
• Wendi Lau, Senior Director, Medical Writing, ASTELLAS
• Douglas Smith, Director, Medical Writing Group Leader,ACTELION PHARMACEUTICALS
• Sophia Kourliouros, Senior Manager, Regulatory Submissions, EISAI
• Dylan Harris, Associate Director, Medical Writing,GENZYME, A SANOFI COMPANY
Cathy Cummins Global Head, Submissions and Documentation NOVARTIS
An exciting event appealing to advanced and beginner writers, providing insight to meet the challenges of changing health authority requirements.
-Cathy Cummins, Global Head, Submissions and Documentation, NOVARTIS“ ”
Neal Azrolan, MBA, PhD, Safety Evaluation and Reporting PFIZER
TO REGISTER CALL: 201 871 0474 TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE
Dear Colleague,
The task facing Regulatory Medical Writers is becoming increasingly more complex. The challenge of interpreting and translating immense amounts of complex clinical data into clear and comprehensive regulatory documents has become overwhelming. In addition, regulatory guidelines are constantly evolving. Navigating the continual changes in ICH guidelines, transparency, clinical trial disclosure, protocol deviation and global submissions is critical to the success of Regulatory Medical Writers. It is critical that they possess a thorough understanding of key documents and regulatory guidelines to ensure efficient product approval.
ExL Pharma’s Clinical Regulatory Medical Writing Forum provides a platform for Medical Writing and Regulatory Submission professionals to learn, benchmark and understand key criteria necessary to effectively compose regulatory documents. This forum will allow delegates to hear industry experts share best practices through case studies, panel discussions and spotlight sessions. Additionally, this two day program will deliver valuable information on a wide variety of important topics including protocol development, Medical Writing outsourcing, global new drug applications, data and information sharing, safety update reports, integrated summaries and many more!
Join us in Philadelphia this July as we tackle the critical issues facing Regulatory Medical Writers!
Sincerely,
Nicole deVoeNicole deVoe Conference Production DirectorExL Pharma
Who Should Attend
This conference is of interest to
professional from Pharmaceutical,
Biotechnology and Medical Device
companies, involved in Clinical
Regulatory Medical Writing with
the following job functions:
• Clinical Medical Writing
• Scientific Writing
• Submissions Management
• Technical Writing
• Regulatory Affairs/Operations
• Clinical Affairs/Operations
• Electronic Submissions
• Medical Affairs
• Publication Writing
• Reporting
• Clinical Documentation
This conference is also of interest to:
• Document Application Suppliers
• Information Management
Consultants
• Clinical Research Organizations
• Research Informatics
• Medical Writing Services
• Bibliographic Software
• Component Authoring Software
• Publication Service Providers
Forum MedicAl WritingClinical Regulatory
SponSorShip And exhibiting opportunitieS Do you want to spread the word about your organization’s solutions and services to potential clients who will be attending this event?Take advantage of the opportunity to exhibit, underwrite an educational session, host a networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to customize a package that will suit all of your needs.
Scott Grossman Production Team Lead ExL Pharma
MEDIA PARTNERS:
TO REGISTER CALL: 201 871 0474 TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE
8:00 Registration and Continental Breakfast
8:45 Chairperson’s Welcome and Opening RemarksCathy Cummins, Global Head, Submissions and Documentation, NOVARTIS
9:00 Management Strategies and Tools for Expediting the Development of Regulatory Submission Protocols • Utilize tools to assist the protocol team to ensure that every
data point needed to be addressed in the clinical study report is captured in the protocol
• Strategies to quickly receive consensus from opposing parties• Ensure clean, consistent and compliant protocolsKim Norris, Director, Medical Writing, SYNTA PHARMACEUTICALS
9:45 Best Practices for Efficient and Effective Composition of Investigator Brochures• Management strategies for effective investigator brochure
composition• Ensure production of investigator brochures is pursuant to
FDA guidelines• Best practices for handling amendmentsJane Stephenson, PhD, MBA, Director of Medical Writing, BOEHRINGER INGELHEIM
10:15 Networking and Refreshment Break
10:45 Medical Writing Challenges in Creating a Global New Drug Application • Regulatory clinical perspective – Focus is on Summary of
Clinical Efficacy (SCE)/ Integrated Summary of Effectiveness (ISE), Summary of Clinical Safety (SCS)/ Integrated Summary of Safety (ISS) and Clinical Overview (CO)
• Review main guidelines associated with regulatorysubmissions
• Aging guidelines: US FDA Clin-Stat guideline (1988) andCommon Technical Document (2003)
• Changing regulatory environment: High profile safety issueshave resulted in more stringent requirements
• Recent guidelines/ guidance documents need to be consideredin the preparation of the dossier
• Possibility of producing a single document for different regions• Can the CTD SCE and SCS fulfill the requirements of the US
ISE and ISS• What region-specific documents may be requested
(e.g., in East Asia and Latin America)Douglas Smith, Director, Medical Writing Group Leader, ACTELION PHARMACEUTICALS
11:30 Use Module 5 Integrated Summaries of Efficacy and Safety to Craft Module 2 Summaries Efficacy and Safety • Understand FDA requirements for Integrated Summaries of
Efficacy and Safety for Module 5 of drug applications • Learn to prepare Module 2 and 5 documents simultaneously,
so that only the Module 5 documents will need to be prepared and rigorously reviewed
Catherine Farrell, PhD, Senior Associate Director, Medical Writing, BOEHRINGER INGELHEIM
12:15 Luncheon
1:15 Challenges, Opportunities and Approaches in a Cross-Functional Review Process• Understand cross-functional reviews and the role(s) of the
Medical Writer • Explore the challenges and opportunities in facilitation and
adjudication of cross-functional reviews• Compliance and its impact on a Medical Writer• Learn tools and approaches for the Medical Writer and their
teamNeal Azrolan, MBA, PhD, Safety Evaluation and Reporting, PFIZER
2:00 Develop Effective Partnerships when Outsourcing Medical Writing Responsibilities • Discuss various models for outsourcing Clinical Regulatory
Medical Writing • Ensure quality standards when outsourcing Medical Writing• Explore the pros and cons of different vehicles for outsourcing
Medical WritingWendi Lau, Senior Director, Medical Writing, ASTELLAS
2:45 Networking and Refreshment Break
3:15 Analyze the Changing Trends in Resourcing • Assessments of the complexity and available workload to
outsource • Ensure document standardization between internal and
outsourced parties • Define clear efficiency and quality KPIsDylan Harris, Associate Director, Medical Writing, GENZYME, A SANOFI COMPANY
4:00 Effectively Prepare Integrated Summaries for the Common Technical Document • Understand ICH M4E Guideline and the need for US
Integrated Summaries and ICH mandated Clinical Summaries when submitting NDAs and sNDAs to the US FDA
• Explore options for efficiently preparing Integrated Summariesof Efficacy, Clinical Summaries of Efficacy, Integrated Summaries of Safety and Clinical Summaries of Safety
• Discuss processes around the preparation of these complexdocuments and the factors used in determining when all document types are required. Also when a single efficacy and single safety summary is acceptable
Dr. Aaron Bernstein, Director, Clinical Medical Writing, ACTAVIS
Sophia Kourliouros, Senior Manager, Regulatory Submissions, EISAI
Cathy Cummins, Global Head, Submissions and Documentation, NOVARTIS
5:00 Conference Chairman’s Closing Remarks Cathy Cummins, Global Head, Submissions and Documentation, NOVARTIS
5:15 Day One Concludes
TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE
dAy one MondAy, July 14, 2014C
ASE
STU
DY
PAN
EL
SESS
ION
TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE TO REGISTER CALL: 201 871 0474 TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE
8:00 Continental Breakfast
9:00 Chairperson’s Recap of Day OneCathy Cummins, Global Head, Submissions and Documentation, NOVARTIS
9:15 Data, Information, Knowledge and Wisdom: Role of the Medical Writer in Clinical Data and Information Sharing • Explore the current requirements and trends in clinical trial
disclosures and how that impacts Medical Writing• Best practices for data and information interpretation:
the importance of context and perspective• Understand the challenges and opportunities for the Medical
WriterNeal Azrolan, MBA, PhD, Safety Evaluation and Reporting, PFIZER
10:00 Implement Component Authoring to Improve Medical Writing Efficiencies • Review of component authoring• Understand the benefits of document reuse• Strategies to change the document writing mindset to
component authoringCathy Cummins, Global Head, Submissions and Documentation, NOVARTIS
10:45 Networking and Refreshment Break
11:15 The Emerging Importance of Patient Reported Outcomes• Discuss the importance of electronic capture of PRO endpoint
data in clinical trials• Explain the design of PRO assessment tools and appropriate
selection and use of such tools• Advantages and disadvantages of working collaboratively
within a pre-competitive consortium to develop and qualifyPRO instruments for use in clinical trials where PROendpoints are used to support product labeling claims
Asha Jayakumar, Scientific Writer, BIOGEN IDEC
12:00 Structured Content Management: A New Approach for Medical Writing in the Pharmaceutical Industry • Introduce structured content management to our industry• Understand benefits of structured content management in
Medical Writing• Learn successful implementation strategiesJoan Affleck, Associate Vice President, Global Head of Clinical Documentation, SANOFI
12:45 Luncheon
1:45 Metrics and Reporting Methodologies to Measure Operational Effectiveness • Measure or quantify the effectiveness of regulatory operations
management• Construct dashboard measurements to employ over time• Analyze KPIs to best allocate resources and manpowerMichael John Mihm, PhD, Associate Medical Writing Program Director, ASTELLAS
2:30 Medical Writing Fellowship Program to Produce Successful Medical Writers • Characteristics and background to look for when hiring a
Medical Writer• Establish programs for successful development of Medical
Writers• Examine aspects of Sanofi Medical Writing Fellowship
programDebra Stamper, Principal Medical Writer, SANOFI
3:15 Conference Chairperson’s Closing Remarks Cathy Cummins, Global Head, Submissions and Documentation, NOVARTIS
3:30 Conference Adjourns
dAy tWo tueSdAy, July 15, 2014
Excellent topics. This looks like a very interesting meeting! - Sr. Director, Global Medical Writing, ALCON LABS
This meeting sounds wonderful! - Sr. Medical Writing Scientist, JOHNSON & JOHNSON
Topics are sure to produce healthy discussions. - Principal Medical Writer, PFIZER
“ ”“ ”“
”
What Your Colleagues are Saying About This Meeting
CA
SE S
TUD
YC
ASE
STU
DY
TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITETO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE
Registration Fees Early Bird Pricing Register by 5/30/2014 ........................... $1895Standard Pricing Register after 5/30/2014 .......................... $2095Onsite Pricing ................................................................. $2195
Questions? Comments?Do you have any questions, comments on the program, or have specific topics you would like addressed? Would you like to get involved as a speaker, moderator or discussion leader? Please email.
Group Discount ProgramsSave 25% per person when registering fourFor every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register four at a time).Save 15% per person when registering threeCan only send three? You can still save 15% on each registration.
Payment Make checks payable to ExL Events, Inc. and write code C523 on your check. You many also use Visa, MasterCard, Discover or American Express. Payments must be received in full by the conference date. Any discount applied cannot be combined with any other offer, and must be paid in full at the time of order. Parties must be employed by the same organization and register simultaneously to realize group discount pricing options. Please note, there will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL conference.
Cancellation PolicyIf you need to cancel your registration for an upcoming ExL conference, please not the following polices derived from the Start Date of the event: Four weeks or more: A full refund (minus $295 processing fee), or a voucher to another ExL event valid for 18 months from the voucher issue date.Four weeks or less: A voucher to another ExL event valid for 18 months from the voucher issue date. If you cancel at any time after receiving the conference documentation, the voucher will be $395 less.To receive a refund or voucher, please fax your request ExL Pharma reserves the right to cancel any conference it deems necessary and will not be responsible for airfare, hotel, or any other costs incurred by registrants. ExL Pharma’s liability is limited to the conference registration fee in the event of a cancellation and does not include changes in program date, content, speaker or venue.
Terms and ConditionsBy registering for an ExL Events, Inc. (“ExL Pharma”) event, you agree to the following set of terms and conditions listed below:Registration Fee: The fee includes the conference, all program materials and designated continental breakfasts, lunches and refreshments.The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL events, Inc.The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL Events, Inc.’s (“ExL’s”) designated speakers and is designed for informational purposes for its attendees, and is NOT INTENDED for purposed of copywriting, not redistribution to other outlets without the express written permission of ExL’s designated speaking par-ties. Neither ExL, nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. EXL EVENTS, INC. EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED OR IMPLIED, AS TO THE ACCURACY OF ANY OF THE CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties, ExL does not guarantee the accuracy of or endorse the views or opinions give by any third party content provider. ExL presentations may point to the other Internet sites that may be of interest to you, however ExL does not endorse or take responsibility for the content on such other sites.
VenueLoews Philadelphia Hotel 1200 Market Street, Philadelphia, PA 19107Direct Line: 215-627-1200Reservations: 888-575-6397To make reservations please call 888-575-6397 and request the negotiated rate for ExL’s July Meeting. The group rate is available until June, 23, 2014. Please book your room early, as rooms available at this rate are limited.
TO REGISTER CALL: 201 871 0474
”
TO REGISTER CALL: 866-207-6528 VISIT: www.ExLphARmA.COm/mEdwRITE TO REGISTER CALL: 201 871 0474
Forum MedicAl WritingClinical Regulatory
July 14-15, 2014 | Loews philadelphia hotel | philadelphia, pA
Aaron Bernstein PhD, Director Clinical Medical WritingACTAVIS
Cathy Cummins Global Head, Submissions and Documentation, NOVARTIS
Neal Azrolan, MBA, PhD, Safety Evaluation and Reporting, PFIZER
Joan Affleck Associate Vice President, Global Head of Clinical Documentation, SANOFI
q YES! Register me for this conference!
Name: _______________________________________________
Title: ________________________________________________
Company: ____________________________________________
Dept: ________________________________________________
Address: _____________________________________________
City: _________________________________________________
State:_________________________Zip:____________________
Email: _______________________________________________
Phone:__ _____________________________________________
Fax: _________________________________________________
Method of Payment: q Check q Credit Card
Make checks payable to: ExL Events, Inc.
Card Type: q MasterCard q Visa q ☐ AMEX
Card Number: _____________________________________________
Exp. Date: __________________________________________________
Name on Card: ______________________________________________
Signature: __________________________________________________
Please contact me:
q I’m interested in marketing opportunities at this event
q I wish to receive email updates on ExL Pharma’s upcoming events
CONFERENCE CODE: C523
top related